NCT02171806View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BI 1744 CL in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2006

Conditions
Healthy
Interventions
DRUG

BI 1744 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY